Lombard Odier & Cie (Canada)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-150
Closed -$22K 63
2016
Q1
$22K Hold
150
0.06% 64
2015
Q4
$24K Hold
150
0.06% 62
2015
Q3
$21K Buy
+150
New +$23.6K 0.06% 73
2015
Q2
Sell
-1,100
Closed -$176K 90
2015
Q1
$176K Hold
1,100
0.28% 63
2014
Q4
$175K Sell
1,100
-6,900
-86% -$1.08M 0.25% 62
2014
Q3
$1.12M Buy
8,000
+1,600
+25% +$209K 0.73% 38
2014
Q2
$757K Buy
+6,400
New +$741K 0.49% 50

Other funds holding AMGN

Lombard Odier & Cie (Canada)'s AMGN Position: Q2 2016 in Review

Lombard Odier & Cie (Canada) sold out of Amgen (AMGN) in Q2 2016, closing a stake of 150 shares — an estimated $22K sold.

Lombard Odier & Cie (Canada) first reported a position in AMGN in Q2 2014 and held it in 7 quarters. The position peaked at $1.12M in Q3 2014. 1,473 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

  • Lombard Odier & Cie (Canada) reported no remaining Amgen position as of Q2 2016 after selling out during the quarter.
  • Lombard Odier & Cie (Canada) sold 150 Amgen shares in Q2 2016, an estimated $22K.
  • Lombard Odier & Cie (Canada) first reported a position in Amgen in Q2 2014 and held it in 7 quarters.
  • Lombard Odier & Cie (Canada)'s Amgen position peaked at $1.12M in Q3 2014.
  • 1,473 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on Lombard Odier & Cie (Canada)'s 13F filing for Q2 2016, filed 15 Aug 2016.